Dermapharm Holding SE (FRA:DMP)

Dermapharm Holding SE Statistics

Total Valuation

FRA:DMP has a market cap or net worth of EUR 1.99 billion. The enterprise value is 2.86 billion.

Market Cap	1.99B
Enterprise Value	2.86B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	+1.51%
Owned by Insiders (%)	6.79%
Owned by Institutions (%)	12.80%
Float	7.77M

Valuation Ratios

The trailing PE ratio is 17.19 and the forward PE ratio is 15.40.

PE Ratio	17.19
Forward PE	15.40
PS Ratio	1.70
PB Ratio	3.09
P/TBV Ratio	n/a
P/FCF Ratio	12.13
P/OCF Ratio	9.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.80, with an EV/FCF ratio of 17.37.

EV / Earnings	24.62
EV / Sales	2.43
EV / EBITDA	10.80
EV / EBIT	12.37
EV / FCF	17.37

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 1.56.

Current Ratio	2.20
Quick Ratio	0.95
Debt / Equity	1.56
Debt / EBITDA	3.84
Debt / FCF	6.15
Interest Coverage	4.40

Financial Efficiency

Return on equity (ROE) is 18.50% and return on invested capital (ROIC) is 8.78%.

Return on Equity (ROE)	18.50%
Return on Assets (ROA)	6.77%
Return on Invested Capital (ROIC)	8.78%
Return on Capital Employed (ROCE)	12.59%
Revenue Per Employee	325,248
Profits Per Employee	32,142
Employee Count	3,610
Asset Turnover	0.55
Inventory Turnover	1.22

Taxes

In the past 12 months, FRA:DMP has paid 57.66 million in taxes.

Income Tax	57.66M
Effective Tax Rate	33.54%

Stock Price Statistics

The stock price has increased by +4.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+4.32%
50-Day Moving Average	33.47
200-Day Moving Average	35.20
Relative Strength Index (RSI)	75.10
Average Volume (20 Days)	19

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:DMP had revenue of EUR 1.17 billion and earned 116.03 million in profits. Earnings per share was 2.15.

Revenue	1.17B
Gross Profit	755.11M
Operating Income	229.76M
Pretax Income	171.90M
Net Income	116.03M
EBITDA	257.07M
EBIT	229.76M
Earnings Per Share (EPS)	2.15

Balance Sheet

The company has 146.58 million in cash and 1.01 billion in debt, giving a net cash position of -864.35 million.

Cash & Cash Equivalents	146.58M
Total Debt	1.01B
Net Cash	-864.35M
Net Cash Per Share	n/a
Equity (Book Value)	646.35M
Book Value Per Share	11.94
Working Capital	350.84M

Cash Flow

In the last 12 months, operating cash flow was 206.50 million and capital expenditures -42.11 million, giving a free cash flow of 164.39 million.

Operating Cash Flow	206.50M
Capital Expenditures	-42.11M
Free Cash Flow	164.39M
FCF Per Share	n/a

Margins

Gross margin is 64.31%, with operating and profit margins of 19.57% and 9.88%.

Gross Margin	64.31%
Operating Margin	19.57%
Pretax Margin	14.64%
Profit Margin	9.88%
EBITDA Margin	21.89%
EBIT Margin	19.57%
FCF Margin	14.00%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 2.42%.

Dividend Per Share	0.90
Dividend Yield	2.42%
Dividend Growth (YoY)	2.27%
Years of Dividend Growth	n/a
Payout Ratio	41.76%
Buyback Yield	0.14%
Shareholder Yield	2.56%
Earnings Yield	5.82%
FCF Yield	8.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:DMP has an Altman Z-Score of 2.22 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	7